The continuous changes in insulin resistance indices during high-risk stages (Q3 and Q4) are consistent with the trajectory showing that HOMA insulin sensitivity decreased steeply until the diagnosis of T2D (Supplemental Figure  1) [24, 25]. The gene discussed is INS; the disease is type 2 diabetes mellitus.